vs

Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and SentinelOne, Inc. (S). Click either name above to swap in a different company.

Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $258.9M, roughly 1.9× SentinelOne, Inc.). Pediatrix Medical Group, Inc. runs the higher net margin — 6.8% vs -23.3%, a 30.1% gap on every dollar of revenue. On growth, SentinelOne, Inc. posted the faster year-over-year revenue change (22.9% vs -1.7%).

Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.

SentinelOne, Inc. is an American cybersecurity company listed on NYSE based in Mountain View, California. The company was founded in 2013 by Tomer Weingarten, Almog Cohen and Ehud ("Udi") Shamir. Weingarten acts as the company's CEO. The company has approximately 2,800 employees and offices in Mountain View, Boston, Prague, Tokyo, and Tel Aviv. The company uses machine learning for monitoring personal computers, IoT devices, and cloud workloads. The company's platform utilizes a heuristic mod...

MD vs S — Head-to-Head

Bigger by revenue
MD
MD
1.9× larger
MD
$493.8M
$258.9M
S
Growing faster (revenue YoY)
S
S
+24.6% gap
S
22.9%
-1.7%
MD
Higher net margin
MD
MD
30.1% more per $
MD
6.8%
-23.3%
S

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
MD
MD
S
S
Revenue
$493.8M
$258.9M
Net Profit
$33.7M
$-60.3M
Gross Margin
73.8%
Operating Margin
9.9%
-28.3%
Net Margin
6.8%
-23.3%
Revenue YoY
-1.7%
22.9%
Net Profit YoY
10.5%
23.1%
EPS (diluted)
$0.40
$-0.18

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MD
MD
S
S
Q4 25
$493.8M
$258.9M
Q3 25
$492.9M
$242.2M
Q2 25
$468.8M
$229.0M
Q1 25
$458.4M
Q4 24
$502.4M
Q3 24
$511.2M
Q2 24
$504.3M
Q1 24
$495.1M
Net Profit
MD
MD
S
S
Q4 25
$33.7M
$-60.3M
Q3 25
$71.7M
$-72.0M
Q2 25
$39.3M
$-208.2M
Q1 25
$20.7M
Q4 24
$30.5M
Q3 24
$19.4M
Q2 24
$-153.0M
Q1 24
$4.0M
Gross Margin
MD
MD
S
S
Q4 25
73.8%
Q3 25
75.0%
Q2 25
75.3%
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Operating Margin
MD
MD
S
S
Q4 25
9.9%
-28.3%
Q3 25
13.8%
-33.3%
Q2 25
12.8%
-38.2%
Q1 25
7.0%
Q4 24
7.8%
Q3 24
6.6%
Q2 24
-31.3%
Q1 24
3.2%
Net Margin
MD
MD
S
S
Q4 25
6.8%
-23.3%
Q3 25
14.5%
-29.7%
Q2 25
8.4%
-90.9%
Q1 25
4.5%
Q4 24
6.1%
Q3 24
3.8%
Q2 24
-30.3%
Q1 24
0.8%
EPS (diluted)
MD
MD
S
S
Q4 25
$0.40
$-0.18
Q3 25
$0.84
$-0.22
Q2 25
$0.46
$-0.63
Q1 25
$0.24
Q4 24
$0.37
Q3 24
$0.23
Q2 24
$-1.84
Q1 24
$0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MD
MD
S
S
Cash + ST InvestmentsLiquidity on hand
$375.2M
$649.8M
Total DebtLower is stronger
$570.5M
Stockholders' EquityBook value
$865.9M
$1.5B
Total Assets
$2.2B
$2.4B
Debt / EquityLower = less leverage
0.66×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MD
MD
S
S
Q4 25
$375.2M
$649.8M
Q3 25
$340.1M
$810.8M
Q2 25
$224.7M
$766.9M
Q1 25
$99.0M
Q4 24
$229.9M
Q3 24
$103.8M
Q2 24
$19.4M
Q1 24
$8.0M
Total Debt
MD
MD
S
S
Q4 25
$570.5M
Q3 25
$577.2M
Q2 25
$583.9M
Q1 25
$590.5M
Q4 24
$597.1M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
MD
MD
S
S
Q4 25
$865.9M
$1.5B
Q3 25
$890.7M
$1.5B
Q2 25
$833.8M
$1.5B
Q1 25
$789.2M
Q4 24
$764.9M
Q3 24
$732.5M
Q2 24
$706.5M
Q1 24
$856.2M
Total Assets
MD
MD
S
S
Q4 25
$2.2B
$2.4B
Q3 25
$2.2B
$2.4B
Q2 25
$2.1B
$2.4B
Q1 25
$2.0B
Q4 24
$2.2B
Q3 24
$2.1B
Q2 24
$2.0B
Q1 24
$2.2B
Debt / Equity
MD
MD
S
S
Q4 25
0.66×
Q3 25
0.65×
Q2 25
0.70×
Q1 25
0.75×
Q4 24
0.78×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MD
MD
S
S
Operating Cash FlowLast quarter
$114.1M
$21.0M
Free Cash FlowOCF − Capex
$20.9M
FCF MarginFCF / Revenue
8.1%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
3.39×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MD
MD
S
S
Q4 25
$114.1M
$21.0M
Q3 25
$137.3M
$-1.0M
Q2 25
$137.2M
$52.3M
Q1 25
$-117.5M
Q4 24
$133.0M
Q3 24
$91.8M
Q2 24
$107.0M
Q1 24
$-125.2M
Free Cash Flow
MD
MD
S
S
Q4 25
$20.9M
Q3 25
$-1.3M
Q2 25
$52.1M
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
FCF Margin
MD
MD
S
S
Q4 25
8.1%
Q3 25
-0.5%
Q2 25
22.8%
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Capex Intensity
MD
MD
S
S
Q4 25
0.0%
Q3 25
0.1%
Q2 25
0.1%
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Cash Conversion
MD
MD
S
S
Q4 25
3.39×
Q3 25
1.91×
Q2 25
3.49×
Q1 25
-5.66×
Q4 24
4.36×
Q3 24
4.72×
Q2 24
Q1 24
-31.03×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MD
MD

Health Care Patient Service$421.6M85%
Hospitals Contracts$70.0M14%
Other$2.2M0%

S
S

US$154.8M60%
Non Us$104.1M40%

Related Comparisons